IMITREX- sumatriptan succinate tablet, film coated United States - English - NLM (National Library of Medicine)

imitrex- sumatriptan succinate tablet, film coated

physicians total care, inc. - sumatriptan succinate (unii: j8bdz68989) (sumatriptan - unii:8r78f6l9vo) - sumatriptan 25 mg - imitrex tablets are indicated for the acute treatment of migraine attacks with or without aura in adults. imitrex tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see contraindications). safety and effectiveness of imitrex tablets have not been established for cluster headache, which is present in an older, predominantly male population. imitrex tablets should not be given to patients with history, symptoms, or signs of ischemic cardiac, cerebrovascular , or peripheral vascular syndromes. in addition, patients with other significant underlying cardiovascular diseases should not receive imitrex tablets. ischemic cardiac syndromes include, but are not limited to, angina pectoris of any type (e.g., stable angina of effort, vasospastic forms of angina such as the prinzmetal variant), all forms of myocardial infarction, and silent myocardial ischemia. cerebrovascular syndromes include, but are not limited to, strokes of any ty